Clinical Trial Update: Functional Respiratory Imaging and Orkambi in CF [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating Functional Respiratory Imaging and Orkambi in cystic fibrosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ORKAMBI (lumacaftor and ivacaftor)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Cystic Fibrosis | Phase 4 | Status: TERMINATED